| Literature DB >> 25603413 |
P Kanske1, S Schönfelder2, J Forneck3, M Wessa2.
Abstract
Deficient emotion regulation has been proposed as a crucial pathological mechanism in bipolar disorder (BD). We therefore investigated emotion regulation impairments in BD, the related neural underpinnings and their etiological relevance for the disorder. Twenty-two euthymic patients with bipolar-I disorder and 17 unaffected first-degree relatives of BD-I patients, as well as two groups of healthy gender-, age- and education-matched controls (N=22/17, respectively) were included. Participants underwent functional magnetic resonance imaging while applying two different emotion regulation techniques, reappraisal and distraction, when presented with emotional images. BD patients and relatives showed impaired downregulation of amygdala activity during reappraisal, but not during distraction, when compared with controls. This deficit was correlated with the habitual use of reappraisal. The negative connectivity of amygdala and orbitofrontal cortex (OFC) observed during reappraisal in controls was reversed in BD patients and relatives. There were no significant differences between BD patients and relatives. As being observed in BD patients and unaffected relatives, deficits in emotion regulation through reappraisal may represent heritable neurobiological abnormalities underlying BD. The neural mechanisms include impaired control of amygdala reactivity to emotional stimuli and dysfunctional connectivity of the amygdala to regulatory control regions in the OFC. These are, thus, important aspects of the neurobiological basis of increased vulnerability for BD.Entities:
Mesh:
Year: 2015 PMID: 25603413 PMCID: PMC4312831 DOI: 10.1038/tp.2014.137
Source DB: PubMed Journal: Transl Psychiatry ISSN: 2158-3188 Impact factor: 6.222
Sample characteristics for BD patients+controls and relatives+controls
| P | P | P | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gender ratio (female/male) | 14/8 | 12/10 | 0.540 | 8/9 | 8/9 | 1.000 | 0.301 | |||
| Age, mean (s.d.) | 39.4 (11.8) | 40.5 (11.8) | 0.770 | 36.7 (16.3) | 35.94 (15.63) | 0.898 | 0.759 | |||
| Years of education, mean (s.d.) | 11.3 (1.6) | 11.8 (1.5) | 0.293 | 12.5 (1.2) | 12.88 (0.33) | 0.175 | 0.011* | |||
| Intelligence score (MWT-B), mean (s.d.) | 105.4 (12.6) | 107.7 (14.4) | 0.592 | 103.1 (11.8) | 109.4 (12.8) | 0.157 | 0.797 | |||
| Married lifetime, | 12 (55.0) | 13 (59.1) | 0.761 | 11 (64.7) | 6 (35.3) | 0.169 | 0.522 | |||
| Currently employed, | 13 (59.1) | 21 (95.5) | 0.004** | 15 (88.2) | 15 (88.2) | 1.000 | 0.045* | |||
| Handedness: LQ-scores, mean (s.d.) | 83.8 (13.8) | 85.7 (23.1) | 0.736 | 57.7 (64.8) | 80.1 (41.1) | 0.238 | 0.071 | |||
| YMRS, mean (s.d.) | 1.0 (1.6) | 0 (0) | 0.008** | 0 (0) | 0 (0) | — | — | 0.018* | ||
| HAMD, mean (s.d.) | 0.7 (1.2) | 0.10 (.4) | 0.029* | 0.3 (1.0) | 0.13 (0.50) | 0.543 | 0.189 | |||
| BDI, mean (s.d.) | 6.7 (6.0) | 1.2 (2.1) | <0.001** | 3.0 (3.3) | 1.76 (3.11) | 0.289 | 0.013* | |||
| BDI, affective subscale, mean (s.d.) | 4.00 (4.5) | 0.7 (1.3) | 0.003** | 1.4 (1.9) | 1.06 (2.41) | 0.694 | 0.013* | |||
| BDI, somatic subscale, mean (s.d.) | 2.7 (2.0) | 0.6 (1.1) | <0.001** | 1.6 (1.8) | 0.71 (0.98) | 0.082 | 0.042* | |||
| Age at onset, mean (s.d.) | 25.2 (7.7) | — | — | — | — | — | — | — | — | — |
| Age at first hospitalization, mean (s.d.) | 27.3 (8.2) | — | — | — | — | — | — | — | — | — |
| No. of hospitalizations, mean (s.d.) | 3.2 (2.5) | — | — | — | — | — | — | — | — | — |
| No. of depressive episodes, mean (s.d.) | 3.6 (2.4) | — | — | — | — | — | — | — | — | — |
| No. of manic episodes, mean (s.d.) | 3.0 (1.8) | — | — | — | — | — | — | — | — | — |
| Time in remission (months), mean (s.d.) | 54.0 (69.0) | — | — | — | — | — | — | — | — | — |
| Regular caffeine, | 14 (66.7) | 17 (81.0) | 0.292 | 10 (62.5) | 13 (81.3) | 0.433 | 0.793 | |||
| Regular nicotine, | 6 (28.6) | 2 (9.1) | 0.101 | 2 (12.5) | 1 (5.9) | 0.601 | 0.239 | |||
| Regular alcohol, | 7 (31.8) | 9 (40.9) | 0.531 | 6 (35.3) | 7 (41.2) | 1.000 | 0.819 | |||
| None, | 3 (13.6) | — | — | — | — | — | — | — | — | — |
| Antidepressants, | 7 (31.8) | — | — | — | — | — | — | — | — | — |
| Benzodiazepines, | 1 (4.5) | — | — | — | — | — | — | — | — | — |
| Antipsychotics, | 12 (54.5) | — | — | — | — | — | — | — | — | — |
| Lithium carbonate, | 8 (36.4) | — | — | — | — | — | — | — | — | — |
| Valproic acid, | 11 (50.0) | — | — | — | — | — | — | — | — | — |
| Lamotrigine, | 6 (27.3) | — | — | — | — | — | — | — | — | — |
Abbreviations: BD, bipolar disorder; BDI, Beck Depression Inventory; Con, control; HAMD, Hamilton Depression Rating Scale; LQ, laterality quotient; MWT-B, Mehrfachwahl-Wortschatztest (premorbid Intelligence); Rel, relative; YMRS, Young Mania Rating Scale.
*P<0.05.
**P<0.01.
Figure 1(a) Sequence of events in a trial. The example pictures resemble those in the experiment, but are not part of the IAPS. (b) Emotional state ratings during the experiment. The means of self-assessment-Manikin-valence-ratings are displayed for BD patients (left), healthy relatives (right) and their respective controls. BD, bipolar disorder; Con, control; IAPS, International Affective Picture System; Rel, relative; SAM, Self-Assessment-Manikin.
Figure 2Increased amygdala activation during reappraisal for BD patients (a) and relatives (b) compared with their respective controls as well as % signal change in the left amygdala. The difference in % signal change between the reappraisal and view conditions correlated negatively with habitual reappraisal use in the CERQ (c), which was also decreased in BD patients and relatives (d). BD, bipolar disorder; CERQ, Cognitive Emotion Regulation Questionnaire; Con, control; Rel, relative.
Activation differences between BD patients, relatives and their respective controls and PPI results
| Z | T | |||||||
|---|---|---|---|---|---|---|---|---|
| x | y | z | ||||||
| Amygdala | L | −21 | −7 | −14 | 20 | 3.06 | 3.32 | |
| R | 33 | 5 | −20 | 26 | 2.87 | 3.09 | ||
| Ventral ACC | L | 10 | −12 | 50 | −2 | 108 | 4.20 | 4.90 |
| Insula | L | 48 | −39 | 2 | −11 | 69 | 3.36 | 3.71 |
| R | 48 | 36 | −16 | 1 | 161 | 3.84 | 4.37 | |
| Amygdala | L | −15 | −4 | −17 | 18 | 2.99 | 3.18 | |
| Amygdala/parahippocampal | R | 21 | 5 | −26 | 60 | 4.31 | 4.87 | |
| Orbitofrontal | L | 47 | −42 | 35 | −8 | 53 | 4.94 | 5.79 |
| Orbitofrontal | L | 47 | −12 | 50 | −5 | 23 | 4.41 | 5.01 |
| Orbitofrontal | L | 47 | −39 | 29 | −14 | 60 | 4.45 | 5.29 |
| R | 47 | 36 | 56 | −8 | 15 | 4.59 | 5.52 | |
| Orbitofrontal | R | 47 | 39 | 56 | −5 | 49 | 5.06 | 6.33 |
Abbreviations: BA, Brodmann area of the peak activation; Con, control; CS, cluster size in number of activated voxels; H, hemisphere; L, left; MNI, Montreal Neurological Institute; PPI, psychophysiological interaction analysis; R, right; Rel, relative.
Figure 3OFC regions of reversed functional connectivity to the left amygdala in BD patients (a) and healthy relatives (b) compared with their respective controls. BD, bipolar disorder; Con, control; OFC, orbitofrontal cortex; Rel, relative.